Medicine
Avonex Pen 30 mcg/0.5 mL injection
Avonex Pen 30 mcg/0.5 mL injection is a prescription medicine containing Interferon beta-1a for intramuscular use, marketed by Biogen, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Refrigerate AVONEX prefilled syringes and autoinjectors at 2°C to 8°C (36°F to…
Key facts
- Active ingredient (INN)
- Interferon beta-1a
- Brand
- Avonex Pen
- Strength
- 30 mcg/0.5 mL
- Dosage form
- Injection
- Route
- Intramuscular
- Packs
- 1 syringe of 0.5 mL
- Marketing authorisation holder
- Biogen
- Manufacturer
- Biogen
- Origin register
- US FDA, United States
- Storage
- Refrigerate AVONEX prefilled syringes and autoinjectors at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. DO NOT FREEZE. Once removed from the refrigerator, allow prefilled syringes and autoinjectors to warm to room temperature (about 30 minutes).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L03AB07 Interferon beta-1a
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 May 2003
- Identifiers
- RxCUI 727813, 727816, 797544 +2DailyMed set ID d70a39cc-de15-4c12-a1ec-8063b69ea0e1NDC 59627-003Application BLA103628
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe in 1 carton / .5 mL in 1 syringe | 59627-003-01 | Biogen | 23 May 2003 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Interferon beta-1a 30 mcg/0.5 mL injection.
Other strengths and forms of Interferon beta-1a
Clinical summary
Interferon beta-1a is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. MedsAcross supplies Interferon beta-1a for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Interferon beta-1aFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Avonex prescribing information (Biogen) · U.S. National Library of Medicine, DailyMed
- Avonex: European public assessment report (EPAR) · European Medicines Agency
- Rebif: European public assessment report (EPAR) · European Medicines Agency
Need Avonex Pen 30 mcg/0.5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.